Authorized Signatory, Morgan Stanley

0000895421-25-000595.txt : 20251205 0000895421-25-000595.hdr.sgml : 20251205 20251205160343 ACCESSION NUMBER: 0000895421-25-000595 CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20251205 DATE AS OF CHANGE: 20251205 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Evoke Pharma Inc CENTRAL INDEX KEY: 0001403708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 208447886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-87872 FILM NUMBER: 251552912 BUSINESS ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-345-1494 MAIL ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MORGAN STANLEY CENTRAL INDEX KEY: 0000895421 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance EIN: 363145972 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A BUSINESS ADDRESS: STREET 1: 1585 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-761-4000 MAIL ADDRESS: STREET 1: 1585 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: MORGAN STANLEY DEAN WITTER & CO DATE OF NAME CHANGE: 19980326 FORMER COMPANY: FORMER CONFORMED NAME: DEAN WITTER DISCOVER & CO DATE OF NAME CHANGE: 19960315 SCHEDULE 13G/A 1 primary_doc.xml SCHEDULE 13G/A 0000895421 XXXXXXXX LIVE 1 Common Stock 11/30/2025 0001403708 Evoke Pharma Inc 30049G302 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 Rule 13d-1(b) Morgan Stanley DE 0 0 0 31 31 N 0.0 HC CO As of the date hereof, Morgan Stanley has ceased to be the beneficial owner of more than five percent of the class of securities. Morgan Stanley Smith Barney LLC DE 0 0 0 31 31 N 0.0 BD IA CO As of the date hereof, Morgan Stanley Smith Barney LLC has ceased to be the beneficial owner of more than five percent of the class of securities. Evoke Pharma Inc 420 STEVENS AVENUE, SUITE 230, SOLANA BEACH, CA, 92075 1: Morgan Stanley 2: Morgan Stanley Smith Barney LLC 1: 1585 Broadway, New York, NY 10036 ;2: 1585 Broadway, New York, NY 10036 1: Delaware 2: Delaware N BD IA HC See the response(s) to Item 9 on the attached cover page(s). 0.0 See the response(s) to Item 5 on the attached cover page(s). See the response(s) to Item 6 on the attached cover page(s). See the response(s) to Item 7 on the attached cover page(s). See the response(s) to Item 8 on the attached cover page(s). N Y Y N See Exhibit 99.2 Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release. EXHIBIT NO. EXHIBITS ------------------ ------------------------------------ 99.1 Joint Filing Agreement 99.2 Item 7 Information * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). Morgan Stanley Chris O'Hara Authorized Signatory, Morgan Stanley 12/05/2025 Morgan Stanley Smith Barney LLC David Galasso Authorized Signatory, Morgan Stanley Smith Barney LLC 12/05/2025 EX-99.1 CHARTER 2 EXHIBIT_NO.99.1.txt EXHIBIT NO. 99.1 TO SCHEDULE 13G JOINT FILING AGREEMENT CUSIP No.30049G302 13G -------------------------------------------------------------------------------- EXHIBIT NO. 99.1 TO SCHEDULE 13G JOINT FILING AGREEMENT --------------------------------------------------- December 05, 2025 --------------------------------------------------- MORGAN STANLEY and Morgan Stanley Smith Barney LLC hereby agree that, unless differentiated, this Schedule 13G is filed on behalf of each of the parties. MORGAN STANLEY BY: /s/ Chris O'Hara --------------------------------------------------------------------- Chris O'Hara/Authorized Signatory, Morgan Stanley Morgan Stanley Smith Barney LLC BY: /s/ David Galasso --------------------------------------------------------------------- David Galasso/Authorized Signatory, Morgan Stanley Smith Barney LLC * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). EX-99.2 OPIN COUNSEL 3 EXHIBIT_NO.99.2.txt EXHIBIT NO. 99.2 ITEM 7 INFORMATION CUSIP No.30049G302 13G -------------------------------------------------------------------------------- EXHIBIT NO. 99.2 ------------------ ITEM 7 INFORMATION The securities being reported on by Morgan Stanley as a parent holding company are owned, or may be deemed to be beneficially owned, by Morgan Stanley Smith Barney LLC, a wholly-owned subsidiary of Morgan Stanley.